ApoB as a Cardiovascular Risk Marker Beyond LDL Cholesterol
Counting artery-damaging particles directly beats estimating them from cholesterol mass alone.
Desmond Achterberg
Senior Contributing Writer
Desmond Achterberg is a former cardiovascular research coordinator who covered preventive cardiology and lipid science for several consumer health outlets before joining Your Lab Explained. He has spent over two decades tracking the evolving evidence on risk stratification and heart-disease prevention.
2 stories
Counting artery-damaging particles directly beats estimating them from cholesterol mass alone.
What actually protects your heart is how well HDL particles work, not the cholesterol number itself.